RE:Last financialsLionWhisperer wrote: 10 million in assets IE pot in storage.Not sure its true value but if one was generous they have 6 milllion in liabilities.The two could washout to balance.Next issue of course Loan payments on the 18.5 million.....I can see a path through if sales materialize and they stop growing more than they can sell.Fat chance of this but slow down expenses till sales catch up..Wild card they will need the 4 to 5 million to keep lights on and move forward and still need to get the sales that have not happened yet.Plus RBC could call the loan. Lots of risks here some rewards but the new buyers on the next financing are going to get half the company on new stock and existing shareholders will be in a fight to get something back......If they pp at 30 or 40 cents(3-4 now) stock goes to 70-90 great for them but is 7-8 great for existing?? Better than 4 or 5 but how much sleep does one want to lose?
I think you're being generous in your estimate of the offering price if, correction when they go to the market looking for capital. My guess is 25 to 30 cents otherwise no one will buy in imo. This all started at 25 cents...
On June 15, 2018, Natural MedCo Ltd. (formerly 1600978 Ontario Inc.) (“Natural MedCo” or the “Target”) completed a brokered private placement of 25,340,000 subscription receipts at a price of $0.25 per subscription receipt and a non-brokered private placement of 17,852,600 common shares at a price of $0.25 per share for gross proceeds of approximately $10.8 million. Concurrently with the closing of the brokered private placement, Natural MedCo completed a private placement of 10,000 debenture units comprised of convertible debentures and common share purchase warrants for gross proceeds of $10 million.
On June 28, 2018, Eve & Co Incorporated (formerly Carlaw Capital V Corp.) (“EVE”) completed its qualifying transaction with the Target, which consisted of the acquisition of all issued and outstanding common shares of the Target by way of a “three-cornered amalgamation” pursuant to the Business Corporations Act (Ontario).
EVE, through its wholly owned subsidiary Natural MedCo, is a licensed producer and seller of dried cannabis and cannabis plants under the Access to Cannabis for Medical Purposes Regulations. On July 4, 2018, EVE began trading on the TSX Venture Exchange under the ticker symbol “EVE”.